Cargando…
Hypoxemic Respiratory Failure Due to Alveolar Pulmonary Sarcoidosis Following COVID-19 Infection
Pulmonary sarcoidosis is typically recognized as an interstitial lung disease with an infrequent occurrence of alveolar filling or acinar pattern. This rare form of alveolar sarcoidosis is known to have a rapid progression. Several case reports showed the development/worsening of sarcoidosis after C...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072786/ https://www.ncbi.nlm.nih.gov/pubmed/37025737 http://dx.doi.org/10.7759/cureus.35790 |
_version_ | 1785019456523599872 |
---|---|
author | Mistry, Hemanshi Y Betancourt, Dominic Schuller, Dan Lavezo, Jonathan |
author_facet | Mistry, Hemanshi Y Betancourt, Dominic Schuller, Dan Lavezo, Jonathan |
author_sort | Mistry, Hemanshi Y |
collection | PubMed |
description | Pulmonary sarcoidosis is typically recognized as an interstitial lung disease with an infrequent occurrence of alveolar filling or acinar pattern. This rare form of alveolar sarcoidosis is known to have a rapid progression. Several case reports showed the development/worsening of sarcoidosis after COVID-19 infection. We present a case of a 60-year-old male with chronic hypoxic respiratory failure since having COVID-19 disease followed by gradual progression in symptoms, who had atypical sarcoid-like alveolar opacities on radiography, two prior negative bronchoscopies, transbronchial biopsy and BAL, and third bronchoscopic transbronchial biopsy suggestive of findings of poorly formed granulomas with high suspicion of alveolar sarcoidosis after ruling out other comparative possibilities, and later having a drastic improvement with sarcoidosis management. Our patient’s worsening symptoms after COVID-19 infection suggest impaired immunoregulation role of the infection in developing the disease process. |
format | Online Article Text |
id | pubmed-10072786 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-100727862023-04-05 Hypoxemic Respiratory Failure Due to Alveolar Pulmonary Sarcoidosis Following COVID-19 Infection Mistry, Hemanshi Y Betancourt, Dominic Schuller, Dan Lavezo, Jonathan Cureus Internal Medicine Pulmonary sarcoidosis is typically recognized as an interstitial lung disease with an infrequent occurrence of alveolar filling or acinar pattern. This rare form of alveolar sarcoidosis is known to have a rapid progression. Several case reports showed the development/worsening of sarcoidosis after COVID-19 infection. We present a case of a 60-year-old male with chronic hypoxic respiratory failure since having COVID-19 disease followed by gradual progression in symptoms, who had atypical sarcoid-like alveolar opacities on radiography, two prior negative bronchoscopies, transbronchial biopsy and BAL, and third bronchoscopic transbronchial biopsy suggestive of findings of poorly formed granulomas with high suspicion of alveolar sarcoidosis after ruling out other comparative possibilities, and later having a drastic improvement with sarcoidosis management. Our patient’s worsening symptoms after COVID-19 infection suggest impaired immunoregulation role of the infection in developing the disease process. Cureus 2023-03-05 /pmc/articles/PMC10072786/ /pubmed/37025737 http://dx.doi.org/10.7759/cureus.35790 Text en Copyright © 2023, Mistry et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Internal Medicine Mistry, Hemanshi Y Betancourt, Dominic Schuller, Dan Lavezo, Jonathan Hypoxemic Respiratory Failure Due to Alveolar Pulmonary Sarcoidosis Following COVID-19 Infection |
title | Hypoxemic Respiratory Failure Due to Alveolar Pulmonary Sarcoidosis Following COVID-19 Infection |
title_full | Hypoxemic Respiratory Failure Due to Alveolar Pulmonary Sarcoidosis Following COVID-19 Infection |
title_fullStr | Hypoxemic Respiratory Failure Due to Alveolar Pulmonary Sarcoidosis Following COVID-19 Infection |
title_full_unstemmed | Hypoxemic Respiratory Failure Due to Alveolar Pulmonary Sarcoidosis Following COVID-19 Infection |
title_short | Hypoxemic Respiratory Failure Due to Alveolar Pulmonary Sarcoidosis Following COVID-19 Infection |
title_sort | hypoxemic respiratory failure due to alveolar pulmonary sarcoidosis following covid-19 infection |
topic | Internal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072786/ https://www.ncbi.nlm.nih.gov/pubmed/37025737 http://dx.doi.org/10.7759/cureus.35790 |
work_keys_str_mv | AT mistryhemanshiy hypoxemicrespiratoryfailureduetoalveolarpulmonarysarcoidosisfollowingcovid19infection AT betancourtdominic hypoxemicrespiratoryfailureduetoalveolarpulmonarysarcoidosisfollowingcovid19infection AT schullerdan hypoxemicrespiratoryfailureduetoalveolarpulmonarysarcoidosisfollowingcovid19infection AT lavezojonathan hypoxemicrespiratoryfailureduetoalveolarpulmonarysarcoidosisfollowingcovid19infection |